ProQR to Participate in Upcoming Investor Conferences in September 2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. NASDAQ:PRQR (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology platform, today an…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.